Previous Close | 0.0800 |
Open | 0.0950 |
Bid | 0.0800 x 0 |
Ask | 0.0950 x 0 |
Day's Range | 0.0950 - 0.0950 |
52 Week Range | 0.0600 - 0.1700 |
Volume | |
Avg. Volume | 15,195 |
Market Cap | 16.048M |
Beta (5Y Monthly) | 1.19 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.5050 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jul 21, 2005 |
1y Target Est | N/A |
Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") today announced the results of its July 19, 2022 annual general meeting of shareholders.
Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that it has borrowed $1 million of working capital funding from one of its investee companies, OncoQuest Inc.
OncoQuest Pharmaceuticals Inc., ("OncoQuest") a clinical-stage biopharmaceutical company focused on the development and commercialization of immunotherapies for cancer, today announces the first patient enrolled in each of two investigator initiated clinical trials assessing the safety and efficacy of oregovomab in a previously treated recurrent ovarian cancer setting.